Growth Metrics

Neogenomics (NEO) Non-Current Debt (2016 - 2020)

Neogenomics filings provide 8 years of Non-Current Debt readings, the most recent being $90.6 million for Q1 2020.

  • On a quarterly basis, Non-Current Debt rose 1712.1% to $90.6 million in Q1 2020 year-over-year; TTM through Mar 2020 was $90.6 million, a 1712.1% increase, with the full-year FY2019 number at $91.8 million, up 4.49% from a year prior.
  • Non-Current Debt hit $90.6 million in Q1 2020 for Neogenomics, down from $91.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $91.8 million in Q4 2019 to a low of $5.0 million in Q1 2019.
  • Median Non-Current Debt over the past 5 years was $52.2 million (2016), compared with a mean of $50.7 million.
  • Biggest five-year swings in Non-Current Debt: crashed 73.84% in 2019 and later surged 1712.1% in 2020.
  • Neogenomics' Non-Current Debt stood at $21.8 million in 2016, then increased by 12.46% to $24.5 million in 2017, then skyrocketed by 258.46% to $87.9 million in 2018, then rose by 4.49% to $91.8 million in 2019, then fell by 1.33% to $90.6 million in 2020.
  • The last three reported values for Non-Current Debt were $90.6 million (Q1 2020), $91.8 million (Q4 2019), and $5.0 million (Q1 2019) per Business Quant data.